Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk

Pharmacogenomics Journal

Volumn 6, Issue 3, 2006, Pages 189-193

  Mikhailova, O N ^a   Gulyaeva, L F ^a   Prudnikov, A V ^a   Gerasimov, A V ^b   Krasilnikov, S E ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b The State Regional Clinical Hospital   (Russian Federation)

Author keywords

Drug metabolizing enzymes; Endometrial cancer; Ovarian cancer; Polymorphism; SNP

Indexed keywords

ARGININE; AROMATASE; CYSTEINE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DNA; ESTROGEN; GUANINE; HISTIDINE; SULFOTRANSFERASE; TYROSINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER PATIENT; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; ESTROGEN METABOLISM; EXON; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GYNECOLOGIC DISEASE; HEALTH CARE FACILITY; HEREDITY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SULFOTRANSFERASES;

EID: 33744523603     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500365     Document Type: Article

References (29)

1. Aksel EM, Davidov MI. Malignant neoplasias in Russia and CIS in 2002. Proc Blokhin RONC RAMS, Moscow 2002: 85-106.
2. Liakhovich VV, Vavilin VA, Grishanova Alu, Makarova SI, Kovalenko SP. Pharmacogenetics and modern medicine. Vestn Ross Akad Med Nauk 2004; 10: 40-45. (in Russian).
3. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21: 427-433.
4. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994; 15: 342-355.
5. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993; 57: 237-257.
6. Badawi AF, Cavalieri EL, Rogan EG. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 2001; 50: 1001-1003.
7. Yamazaki H, Shaw PM, Guengerich FP, Shimada T. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 1998; 11: 659-665.
8. Xu X, Duncan AM, Merz-Demlow BE, Phipps WR, Kurzer MS. Menstrual cycle effects on urinary estrogen metabolites. J Clin Endocrinol Metab 1999; 84: 3914-3918.
9. Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000; 27: 113-124.
10. Kiyohara C, Nakanishi Y, Inutsuka S, Takayama K, Hara N, Motohiro A et al. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics 1998; 8: 315-323.
11. Catteau A, Bechtel YC, Poisson N, Bechtel PR, Bonaiti-Pellie C. A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmacol 1995; 47: 423-430.
12. Eaton DL, Gallagher EP, Bammler TK, Kunze KL. Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity. Pharmacogenetics 1995; 5: 259-274.
13. Christiansen L, Bygum A, Jensen A, Thomsen K, Brandrup F, Horder M et al. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet 2000; 107: 612-614.
14. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 2001; 10: 209-216.
15. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997; 23: 298-304.
16. Sasaki M, Kotcherguina L, Dharia A, Fujimoto S, Dahiya R. Cytosinephosphoguanine methylation of estrogen receptors in endometrial cancer. Cancer Res 2001; 61: 3262-3266.
17. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Davis S et al. Local estrogen biosynthesis in males and females. Endocrine-Related Cancer 1999; 6: 131-137.
18. Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004; 5: 57-65.
19. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414-423.
20. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996; 36: 203-232.
21. Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: Allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 2003; 55: 68-76.
22. Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E et al. Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000; 60: 6859-6863.
23. Coughtrie MW, Johnston LE. Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab Dispos 2001; 29: 522-528.
24. Adjei AA, Thomae BA, Prondzinski JL, Eckloff BW, Wieben ED, Weinshilboum RM. Human estrogen sulfotransferase (SULT1 E1) pharmacogenomics: Gene resequencing and functional genomics. Br J Pharmacol 2003; 39: 1373-1382.
25. Li Yu, Millikan RC, Bell DA, Cui L, Tse JCK, Newman B et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 2004; 6: R460-R473.
26. Tsuchiya M, Nakao H, Katoh T, Sasaki H, Hiroshima M, Tanaka T et al. Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 2005; 20: 974-978.
27. Simpson ER, Davis SR. Minireview: Aromatase and the regulation of estrogen biosynthesis - some new perspectives. Endocrinology 2001; 142: 4589-4594.
28. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Rew 1998; 19: 593-607.
29. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003; 86: 225-230.